Auto-oxidation of Isoniazid Leads to Isonicotinic-Lysine Adducts on Human Serum Albumin
- 9 December 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 28 (1) , 51-58
Abstract
Isoniazid (INH), a widely used antituberculosis drug, has been associated with serious drug-induced liver injury (DILI). INH-modified proteins have been proposed to play important roles in INH DILI; however, it remains to be determined whether INH or reactive metabolites bind irreversibly to proteins. In this study, mass spectrometry was used to define protein modifications by INH in vitro and in patients taking INH therapy. When INH was incubated with N-acetyl lysine (NAL), the same isonicotinic-NAL (IN-NAL) adducts were detected irrespective of the presence or absence of any oxidative enzymes, indicating auto-oxidation may have been involved. In addition, we found that INH could also bind to human serum albumin (HSA) via an auto-oxidation pathway, forming isonicotinic amide adducts with lysine residues in HSA. Similar adducts were detected in plasma samples isolated from patients taking INH therapy. Our results show that INH forms protein adducts in the absence of metabolism.Keywords
Funding Information
- Medical Research Council Centre for Drug Safety Science (G0700654)
This publication has 32 references indexed in Scilit:
- N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient groupEuropean Journal of Clinical Pharmacology, 2014
- Role of CYP3A in Isoniazid Metabolism In VivoDrug Metabolism and Pharmacokinetics, 2014
- Detection of anti-isoniazid and anti–cytochrome P450 antibodies in patients with isoniazid-induced liver failureHepatology, 2013
- Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapyNature Medicine, 2013
- Mechanistic investigation of the oxidation of hydrazides: implications for the activation of the TB drug isoniazidOrganic & Biomolecular Chemistry, 2012
- Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and Human Hepatic Microsomes: Humans Are More Like Mice than RatsChemical Research in Toxicology, 2012
- A Novel Metabolite of Antituberculosis Therapy Demonstrates Host Activation of Isoniazid and Formation of the Isoniazid-NAD+AdductAntimicrobial Agents and Chemotherapy, 2012
- A Fresh Look at the Mechanism of Isoniazid-Induced HepatotoxicityClinical Pharmacology & Therapeutics, 2011
- Metabolomic Analysis Reveals Novel Isoniazid Metabolites and Hydrazones in Human UrineDrug Metabolism and Pharmacokinetics, 2011
- The Role of Metabolism in the Hepatotoxicity of Isoniazid and IproniazidDrug Metabolism Reviews, 1979